Autres langues Helixmith Co., Ltd

Actions

A084990

KR7084990001

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
4 260 ^KRW	-3,40 %		-4,80 %	-30,96 %

2023	Helixmith Co., Ltd présente ses résultats pour le premier trimestre clos le 31 mars 2023	CI
2022	Les actions sud-coréennes chutent de près de 2 % en raison des craintes de hausse des taux aux États-Unis ; Samsung perd 2 %.	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Helixmith Co., Ltd announced that it has received KRW 3.37919826 billion in funding	25/04
Helixmith Co., Ltd announced that it expects to receive KRW 3.37919826 billion in funding	05/02
Helixmith Stock Plummets Following Clinical Setback in Gene Therapy Candidate	04/01
Helixmith Co., Ltd announced that it has received KRW 36.57534969 billion in funding from Bio Solution Co.,Ltd.	28/12
Helixmith Co., Ltd announced that it expects to receive KRW 36.57534969 billion in funding from Bio Solution Co.,Ltd.	20/12
Helixmith Co., Ltd announced that it has received KRW 19.999986156 billion in funding from CANARIABIO M Inc.	31/08/23
Helixmith Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Diabetic Foot Ulcers Pipeline Assets Segmented by Stage, Product Type, Route of Administration, and Molecule Type	14/03/23
Helixmith Co., Ltd announces tranche update	15/02/23
Helixmith Co., Ltd announced that it expects to receive KRW 19.999986156 billion in funding from CANARIABIO M Inc.	07/02/23
Helixmith Co., Ltd announced that it has received KRW 34.99999386 billion in funding from CANARIABIO M Inc.	29/12/22
Sejong Medical Co., Ltd. announced that it has received KRW 30 billion in funding from Helixmith Co., Ltd	29/12/22
South Korean Stocks Decline Nearly 2% over Rate Hike Fears in the US; Samsung Loses 2%	23/12/22
Helixmith to Raise 35 Billion Won From Stock Sale; Shares Decline 7%	23/12/22
Helixmith Co., Ltd announced that it expects to receive KRW 34.99999386 billion in funding from CANARIABIO M Inc.	21/12/22
Sejong Medical Co., Ltd. announced that it expects to receive KRW 30 billion in funding from Helixmith Co., Ltd	21/12/22
Helixmith : to Present New ALS-Focused Development Program at Upcoming Conferences	05/10/22
Helixmith Co., Ltd(KOSDAQ:A084990) dropped from FTSE All-World Index	19/09/22
Helixmith : Announces Topline Results from Phase 2A Study of Engensis for Treatment of ALS	08/09/22
Helixmith Announces Topline Results from Phase 2A Study of Engensis for Treatment of ALS (Amyotrophic Lateral Sclerosis)	06/09/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Helixmith Co., Ltd

Actions

A084990

KR7084990001

Autres langues

Filtres